Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma
Hyun Kyung Kong et al, 2016, Oncotarget CrossRef
Harnessing traditional Chinese medicine to improve cancer therapy: issues for future development
Doreen Pon et al, 2010, Therapeutic Delivery CrossRef
Evidence-based Anticancer Materia Medica for Lung Cancer
Constance L. L. Saw et al, 2012, Materia Medica for Various Cancers CrossRef
Anti-proliferative effects of raw and steamed extracts of Panax notoginseng and its ginsenoside constituents on human liver cancer cells
Ding-Fung Toh et al, 2011, Chinese Medicine CrossRef
Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome
Linlin Luo et al, 2016, Oncotarget CrossRef
Panax notoginseng Inhibits Tumor Growth through Activating Macrophage to M1 Polarization
Bosung Kim et al, 2018, The American Journal of Chinese Medicine CrossRef
Recombinant SLURP-1 Inhibits Growth and Migration of U251 MG Glioma by Cell Cycle Arrest and Modulation of MAPK and AKT Signaling Pathways
M. A. Shulepko et al, 2023, Биоорганическая химия CrossRef
Recombinant SLURP-1 Inhibits Growth and Migration of U251 MG Glioma by Cell Cycle Arrest and Modulation of MAPK and AKT Signaling Pathways
M. A. Shulepko et al, 2023, Russian Journal of Bioorganic Chemistry CrossRef
Systematic Review of Case Reports about Korean Medicine for Lung Cancer
Gajin Han et al, 2018, Journal of Korean Medicine CrossRef
Cell penetrating peptides: Highlighting points in cancer therapy
Akmal M. Asrorov et al, 2023, Drug Development Research CrossRef
miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer
Ye Sol Kim et al, 2106, Oncotarget CrossRef
Modified Panax ginseng Extract Inhibits uPAR-Mediated α5β1-Integrin Signaling by Modulating Caveolin-1 to Induce Early Apoptosis in Lung Cancer Cells
In-Hu Hwang et al, 2016, The American Journal of Chinese Medicine CrossRef